Aurora Cannabis (ACB) Projected to Post Earnings on Thursday

Aurora Cannabis (NASDAQ:ACB) will likely be issuing its quarterly earnings data before the market opens on Thursday, February 13th. Analysts expect the company to announce earnings of $0.04 per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

Aurora Cannabis (NASDAQ:ACB) last announced its earnings results on Wednesday, February 5th. The company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.15. Aurora Cannabis had a net margin of 0.42% and a return on equity of 0.59%. On average, analysts expect Aurora Cannabis to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Aurora Cannabis Trading Down 2.9 %

Shares of NASDAQ:ACB opened at $6.42 on Wednesday. Aurora Cannabis has a 52-week low of $2.84 and a 52-week high of $9.35. The stock has a market capitalization of $352.20 million, a price-to-earnings ratio of 128.43 and a beta of 1.84. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.88 and a current ratio of 3.30. The stock’s 50-day simple moving average is $4.35 and its two-hundred day simple moving average is $5.16.

Analysts Set New Price Targets

ACB has been the topic of a number of analyst reports. Atb Cap Markets upgraded shares of Aurora Cannabis from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 5th. TD Securities raised shares of Aurora Cannabis to a “strong-buy” rating in a research note on Thursday, December 12th. Finally, TD Cowen began coverage on shares of Aurora Cannabis in a research note on Wednesday, December 11th. They issued a “buy” rating on the stock.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.